Efficacy and Safety of Daptomycin in Patients with Renal Impairment: A Multicenter Retrospective AnalysisKULLAR, Ravina; MCCLELLAN, Ian; GERIAK, Matthew et al.Pharmacotherapy. 2014, Vol 34, Num 6, pp 582-589, issn 0277-0008, 8 p.Conference Paper

Avoiding the Perfect Storm: The Biologic and Clinical Case for Reevaluating the 7-Day Expectation for Methicillin-Resistant Staphylococcus aureus Bacteremia Before Switching TherapyKULLAR, Ravina; MCKINNELL, James A; SAKOULAS, George et al.Clinical infectious diseases. 2014, Vol 59, Num 10, pp 1455-1461, issn 1058-4838, 7 p.Article

Comparative Epidemiology of Bacteremia due to Methicillin-Resistant Staphylococcus aureus between Older and Younger Adults: A Propensity Score AnalysisKULLAR, Ravina; RYBAK, Michael J; KAYE, Keith S et al.Infection control and hospital epidemiology. 2013, Vol 34, Num 4, pp 400-406, issn 0899-823X, 7 p.Article

The Epic Challenge of Optimizing Antimicrobial Stewardship: The Role of Electronic Medical Records and TechnologyKULLAR, Ravina; GOFF, Debra A; SCHULZ, Lucas T et al.Clinical infectious diseases. 2013, Vol 57, Num 7, pp 1005-1013, issn 1058-4838, 9 p.Article

Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient CohortKULLAR, Ravina; DAVIS, Susan L; TAYLOR, Thomas N et al.Pharmacotherapy. 2012, Vol 32, Num 3, pp 195-201, issn 0277-0008, 7 p.Article

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested TargetsKULLAR, Ravina; DAVIS, Susan L; LEVINE, Donald P et al.Clinical infectious diseases. 2011, Vol 52, Num 8, pp 975-981, issn 1058-4838, 7 p.Article

Implementation of an Antimicrobial Stewardship Pathway with Daptomycin for Optimal Treatment of Methicillin-Resistant Staphylococcus aureus BacteremiaKULLAR, Ravina; DAVIS, Susan L; KAYE, Keith S et al.Pharmacotherapy. 2013, Vol 33, Num 1, pp 3-10, issn 0277-0008, 8 p.Article

Pharmacokinetics of Single-Dose Daptomycin in Patients with Suspected or Confirmed Neurological InfectionsKULLAR, Ravina; CHIN, Judy N; EDWARDS, David J et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 7, pp 3505-3509, issn 0066-4804, 5 p.Article

Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration > 1 mg/L: A Matched Cohort StudyMURRAY, Kyle P; ZHAO, Jing J; DAVIS, Susan L et al.Clinical infectious diseases. 2013, Vol 56, Num 11, pp 1562-1569, issn 1058-4838, 8 p.Article

Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15―20 mg/L Suggested by the Vancomycin Consensus GuidelinesKULLAR, Ravina; LEONARD, Steven N; DAVIS, Susan L et al.Pharmacotherapy. 2011, Vol 31, Num 5, pp 441-448, issn 0277-0008, 8 p.Article

High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective StudyKULLAR, Ravina; DAVIS, Susan L; LEVINE, Donald P et al.Pharmacotherapy. 2011, Vol 31, Num 6, pp 527-536, issn 0277-0008, 10 p.Article

Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus CeftarolineSAKOULAS, George; MOISE, Pamela A; GOFF, Debra A et al.Clinical therapeutics. 2014, Vol 36, Num 10, pp 1317-1333, issn 0149-2918, 17 p.Article

Evaluation of Vancomycin Population Susceptibility Analysis Profile as a Predictor of Outcomes for Patients with Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureusCASAPAO, Anthony M; DAVIS, Susan L; MCROBERTS, John Paul et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4636-4641, issn 0066-4804, 6 p.Article

Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal InfectionsCASAPAO, Anthony M; KULLAR, Ravina; COSGROVE, Sara E et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4190-4196, issn 0066-4804, 7 p.Article